Table 2 Analysis of efficacy adjusting for prior use of cannabis
Source | P-value | ||||
|---|---|---|---|---|---|
Model 1 | Model 2 | Model 3 | Model 4 | Model 5 | |
Baseline severity (BS) | <0.0001 | ||||
Study (ST) | 0.052 | ||||
Prior cannabis (PC) | 0.105 | ||||
Treatment group (TG) | 0.033 | ||||
TG*PC | 0.962 | 0.637 | 0.561 | 0.626 | |
PC*ST | 0.497 | 0.514 | 0.495 | ||
TG*ST | 0.810 | 0.720 | |||
TG*PC*ST | 0.188 | ||||
Estimated effect of previous cannabis use on spasticity NRS (95% CI) | Previous users: | −1.23 (−1.43 to −1.04) | |||
No previous use: | −0.98 (−1.22 to −0.74) | ||||
Estimated difference: | −0.25 (−0.56 to 0.05) | ||||